375 related articles for article (PubMed ID: 14656807)
1. The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats.
Elmedal B; de Dam MY; Mulvany MJ; Simonsen U
Br J Pharmacol; 2004 Jan; 141(1):105-13. PubMed ID: 14656807
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy is unaltered by long-term oral L-arginine administration.
Laursen BE; Dam MY; Mulvany MJ; Simonsen U
Vascul Pharmacol; 2008; 49(2-3):71-6. PubMed ID: 18499529
[TBL] [Abstract][Full Text] [Related]
3. Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats.
Andersen CU; Mulvany MJ; Simonsen U
Eur J Pharmacol; 2005 Mar; 510(1-2):87-96. PubMed ID: 15740728
[TBL] [Abstract][Full Text] [Related]
4. Tempol improves vascular function in the mesenteric vascular bed of senescent rats.
Tatchum-Talom R; Martin DS
Can J Physiol Pharmacol; 2004 Mar; 82(3):200-7. PubMed ID: 15052286
[TBL] [Abstract][Full Text] [Related]
5. Long-acting phosphodiesterase 5 inhibitor, tadalafil, and superoxide dismutase mimetic, tempol, protect against acute hypoxia-induced pulmonary hypertension in rats.
Rashid M; Kotwani A; Fahim M
Hum Exp Toxicol; 2012 Jun; 31(6):626-36. PubMed ID: 22144729
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of tadalafil in chronic hypobaric hypoxia-induced pulmonary hypertension: possible mechanisms.
Rashid M; Fahim M; Kotwani A
Fundam Clin Pharmacol; 2013 Jun; 27(3):271-8. PubMed ID: 22251079
[TBL] [Abstract][Full Text] [Related]
7. BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats.
Thorsen LB; Eskildsen-Helmond Y; Zibrandtsen H; Stasch JP; Simonsen U; Laursen BE
Eur J Pharmacol; 2010 Nov; 647(1-3):147-54. PubMed ID: 20828552
[TBL] [Abstract][Full Text] [Related]
8. Prolonged nitric oxide inhalation during recovery from chronic hypoxia does not decrease nitric oxide-dependent relaxation in pulmonary arteries.
Maruyama J; Jiang BH; Maruyama K; Takata M; Miyasaka K
Chest; 2004 Dec; 126(6):1919-25. PubMed ID: 15596693
[TBL] [Abstract][Full Text] [Related]
9. Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance.
Viswanad B; Srinivasan K; Kaul CL; Ramarao P
Pharmacol Res; 2006 Mar; 53(3):209-15. PubMed ID: 16412660
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats.
Partovian C; Adnot S; Raffestin B; Louzier V; Levame M; Mavier IM; Lemarchand P; Eddahibi S
Am J Respir Cell Mol Biol; 2000 Dec; 23(6):762-71. PubMed ID: 11104729
[TBL] [Abstract][Full Text] [Related]
11. Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats.
Jankov RP; Kantores C; Pan J; Belik J
Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L233-45. PubMed ID: 18083771
[TBL] [Abstract][Full Text] [Related]
12. Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
Markvardsen LK; Sønderskov LD; Wandall-Frostholm C; Pinilla E; Prat-Duran J; Aalling M; Mogensen S; Andersen CU; Simonsen U
J Vasc Res; 2021; 58(4):237-251. PubMed ID: 33910208
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity.
Snow JB; Kitzis V; Norton CE; Torres SN; Johnson KD; Kanagy NL; Walker BR; Resta TC
J Appl Physiol (1985); 2008 Jan; 104(1):110-8. PubMed ID: 17947499
[TBL] [Abstract][Full Text] [Related]
14. Flow- and acetylcholine-induced dilatation in small arteries from rats with renovascular hypertension--effect of tempol treatment.
Christensen FH; Stankevicius E; Hansen T; Jørgensen MM; Valverde VL; Simonsen U; Buus NH
Eur J Pharmacol; 2007 Jul; 566(1-3):160-6. PubMed ID: 17482591
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress.
Jerkic M; Kabir MG; Davies A; Yu LX; McIntyre BA; Husain NW; Enomoto M; Sotov V; Husain M; Henkelman M; Belik J; Letarte M
Cardiovasc Res; 2011 Dec; 92(3):375-84. PubMed ID: 21859819
[TBL] [Abstract][Full Text] [Related]
17. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
[TBL] [Abstract][Full Text] [Related]
18. The NO donor molsidomine reduces endothelin-1 gene expression in chronic hypoxic rat lungs.
Blumberg FC; Wolf K; Sandner P; Lorenz C; Riegger GA; Pfeifer M
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L258-63. PubMed ID: 11159004
[TBL] [Abstract][Full Text] [Related]
19. Superoxide dismutase mimetic tempol inhibits hypoxic pulmonary vasoconstriction in rats independently of nitric oxide production.
Hodyc D; Snorek M; Brtnický T; Herget J
Exp Physiol; 2007 Sep; 92(5):945-51. PubMed ID: 17496002
[TBL] [Abstract][Full Text] [Related]
20. Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.
Mam V; Tanbe AF; Vitali SH; Arons E; Christou HA; Khalil RA
J Pharmacol Exp Ther; 2010 Feb; 332(2):455-62. PubMed ID: 19915069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
